A

Amgen

Makes biotech medicines for serious illnesses

Director – Risk-Based Quality Management (RBQM) Platforms & Technology

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeHyderabad, Telangana, IndiaNo salary listedIn-person

About the Job

Requirements

  • A Master's degree and 12 or more years of clinical data landscape transformation execution experience, or a Bachelor's degree and 15 or more years of clinical data and its technology transformation experience.
  • Five years of managerial experience directly managing people and/or leadership experience leading teams, projects, programs, or directing resource allocation.
  • Fifteen or more years of experience in clinical development, clinical operations, business transformation, large-scale technology and business process transformation, or related functions within the biopharmaceutical industry is preferred.
  • Demonstrated success leading large-scale enterprise transformation initiatives, including technology transformation, process modernization, organizational change management, and business capability development is preferred.
  • Experience implementing and scaling AI-enabled RBQM solutions, automation technologies, advanced analytics, and digital capabilities within clinical development or other regulated environments is preferred.
  • Proven ability to establish and lead as a business product owner supporting complex, cross-functional strategic initiatives and program execution is preferred.
  • Exposure to global trends and understanding of regulatory requirements and RBQM-based clinical trial management are preferred.
  • Experience with AI, digital health, and informatics tools that may advance ways of working within the clinical trial ecosystem is preferred.
  • Enterprise cross-functional leadership across the clinical data landscape with deep functional process expertise.
  • Deep understanding of RBQM principles, central monitoring methodologies, risk analytics, quality management frameworks, Good Clinical Practice expectations, and RBQM technology platforms supporting modern clinical trial oversight.
  • Expertise leading large-scale transformation initiatives involving processes and foundational technologies for Global Development Operations.
  • Experience driving process, data, and technology transformation, digital enablement, and organizational change management within highly matrixed environments.

Responsibilities

  • Define and lead the enterprise Risk-Based Quality Management strategy, establishing a framework that uses central monitoring, analytics, automation, and AI-enabled insights to improve study quality, execution, and patient outcomes.
  • Establish the operating model, governance framework, standards, and business processes to transition from traditional oversight to proactive, data-driven risk management across the clinical trial lifecycle.
  • Lead evolution of RBQM platforms, data assets, analytics capabilities, and risk intelligence solutions to support business needs and regulatory expectations.
  • Champion advanced analytics, artificial intelligence, central monitoring, and predictive risk indicators to identify study, site, patient, data quality, and operational risks earlier across the portfolio.
  • Partner with Study Start-Up, Site & Study Operations, Data Management, Biostatistics, Study Teams, Clinical Systems, AI&D, DTI, and business leadership to align RBQM capabilities with transformation objectives.
  • Represent Amgen in industry working groups, technology partnerships, and external forums to shape RBQM, central monitoring, digital trial oversight, and risk-based quality strategies while aligning with evolving regulatory expectations.
  • Lead implementation, adoption, and continuous enhancement of RBQM platforms and central monitoring capabilities, integrating them into study start-up, study conduct, risk review, and quality management processes.
  • Establish operational processes, dashboards, analytics, and workflows that give study teams, Study Start-Up, Site & Study Operations, and Data Management actionable insights to identify, assess, escalate, and mitigate risks.
  • Deliver integrated data ecosystems connecting clinical, operational, site, quality, and risk information to support central monitoring, portfolio oversight, decision-making, and execution.
  • Define and track value-based key performance indicators for study start-up timelines, site activation, monitoring effectiveness, protocol compliance, issue resolution, study quality, operational efficiency, and trial execution.
  • Build and lead a high-performing organization focused on delivering the Global Development Operations Strategic Business Plan and enterprise transformation commitments.
  • Lead, mentor, and develop a global team and foster accountability, agility, collaboration, innovation, and continuous improvement.
  • Develop organizational capabilities, operating models, and skillsets to support evolving business, technology, and portfolio needs.
  • Partner with Global Development Operations leadership and enterprise stakeholders to align transformation priorities, resource needs, and execution plans.
  • Collaborate with external life sciences organizations, technology and software-as-a-service providers, AI&D, DTI, and Global Development Operations functions to align and execute strategic initiatives, transformation activities, and operational priorities.
  • Support evaluation and integration of new technologies, external partnerships, and organizational transformation opportunities, including mergers and acquisitions as applicable.
  • Monitor industry trends, competitive capabilities, and innovation opportunities that may improve operational quality, efficiency, speed, and scalability.

Desired Qualifications

  • The candidate should embody Amgen's leadership attributes: inspire by creating an inclusive work environment; accelerate progress; integrate cross-functional efforts to drive results; and adapt to change while defining a course of action.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs